JP2009540852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009540852A5 JP2009540852A5 JP2009517228A JP2009517228A JP2009540852A5 JP 2009540852 A5 JP2009540852 A5 JP 2009540852A5 JP 2009517228 A JP2009517228 A JP 2009517228A JP 2009517228 A JP2009517228 A JP 2009517228A JP 2009540852 A5 JP2009540852 A5 JP 2009540852A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- antigen
- nos
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 24
- 108020004707 nucleic acids Proteins 0.000 claims 17
- 239000000427 antigen Substances 0.000 claims 16
- 102000038129 antigens Human genes 0.000 claims 15
- 108091007172 antigens Proteins 0.000 claims 15
- 229920001184 polypeptide Polymers 0.000 claims 14
- 230000027455 binding Effects 0.000 claims 11
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 10
- 206010060862 Prostate cancer Diseases 0.000 claims 10
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 9
- 239000003446 ligand Substances 0.000 claims 9
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 210000004027 cells Anatomy 0.000 claims 5
- 102000005614 monoclonal antibodies Human genes 0.000 claims 5
- 108010045030 monoclonal antibodies Proteins 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 230000001809 detectable Effects 0.000 claims 4
- 238000009007 Diagnostic Kit Methods 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000001514 detection method Methods 0.000 claims 3
- 101700027111 3SA0 Proteins 0.000 claims 2
- 210000000612 Antigen-Presenting Cells Anatomy 0.000 claims 2
- 210000004443 Dendritic Cells Anatomy 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 210000002307 Prostate Anatomy 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 238000004166 bioassay Methods 0.000 claims 2
- 230000001413 cellular Effects 0.000 claims 2
- 101700067609 ctx Proteins 0.000 claims 2
- 231100000599 cytotoxic agent Toxicity 0.000 claims 2
- 239000002619 cytotoxin Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drugs Drugs 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- 229960005486 vaccines Drugs 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 1
- 229920000272 Oligonucleotide Polymers 0.000 claims 1
- 210000000400 T-Lymphocytes, Cytotoxic Anatomy 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000890 antigenic Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000002860 competitive Effects 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims 1
- 229910052738 indium Inorganic materials 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000000159 protein binding assay Methods 0.000 claims 1
- 229920002033 ribozyme Polymers 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims 1
- 229910052727 yttrium Inorganic materials 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81768606P | 2006-07-03 | 2006-07-03 | |
| PCT/EP2007/056584 WO2008003656A2 (en) | 2006-07-03 | 2007-06-29 | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009540852A JP2009540852A (ja) | 2009-11-26 |
| JP2009540852A5 true JP2009540852A5 (de) | 2010-08-05 |
Family
ID=38537749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009517228A Pending JP2009540852A (ja) | 2006-07-03 | 2007-06-29 | 前立腺特異的な転写物ならびに前立腺癌の治療および診断におけるその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120141376A1 (de) |
| EP (1) | EP2044216A2 (de) |
| JP (1) | JP2009540852A (de) |
| KR (1) | KR20090111307A (de) |
| CN (1) | CN101506376A (de) |
| AU (1) | AU2007271232A1 (de) |
| CA (1) | CA2656140A1 (de) |
| IL (1) | IL196184A0 (de) |
| WO (1) | WO2008003656A2 (de) |
| ZA (1) | ZA200900794B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8778621B2 (en) * | 2009-05-12 | 2014-07-15 | Koninklijke Philips N.V. | Phosphodiesterase 4D7 as marker for malignant, hormone-sensitive prostate cancer |
| DE102012203547A1 (de) * | 2012-03-07 | 2013-09-12 | Robert Bosch Gesellschaft Für Medizinische Forschung Mbh | Antimikrobielle Peptide |
| PE20150333A1 (es) * | 2012-03-05 | 2015-03-25 | Arctic Partners Ab Oy | Metodos y aparatos para predecir riesgo de cancer de prostata y volumen de glandula prostatica |
| TWI687688B (zh) | 2014-03-28 | 2020-03-11 | 美商Ｏｐｋｏ診斷法有限責任公司 | 與前列腺癌診斷相關之組合物及方法 |
| KR101698654B1 (ko) | 2014-12-24 | 2017-01-20 | 포항공과대학교 산학협력단 | En2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| ES2867798T3 (es) | 2015-03-27 | 2021-10-20 | Opko Diagnostics Llc | Estándares del antígeno prostático y usos de estos |
| EP3286565A1 (de) * | 2015-04-21 | 2018-02-28 | Genentech, Inc. | Zusammensetzungen und verfahren für prostatakrebsanalyse |
| EP3344034A1 (de) * | 2015-09-02 | 2018-07-11 | Regeneron Pharmaceuticals, Inc. | Nagetiermodell von prostatakrebs |
| KR101777085B1 (ko) | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| CN111383757B (zh) * | 2020-03-04 | 2023-08-25 | 南京亿科人群健康研究院有限公司 | 一种计算机辅助开发包虫病诊断试剂盒的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2775984B1 (fr) * | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
| AU3305699A (en) * | 1998-02-26 | 1999-09-15 | Beckman Coulter, Inc. | Prostate-specific membrane antigens and methods of making and using |
| WO2001055387A1 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| US20030099974A1 (en) * | 2001-07-18 | 2003-05-29 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer |
| US20040126762A1 (en) * | 2002-12-17 | 2004-07-01 | Morris David W. | Novel compositions and methods in cancer |
| EP1483381A2 (de) * | 2002-03-14 | 2004-12-08 | Exonhit Therapeutics S.A. | Varianten der humanen kallikrein-2 und kallikrein-3 und ihre verwendungen |
| WO2004113571A2 (en) * | 2003-06-26 | 2004-12-29 | Exonhit Therapeutics Sa | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis |
-
2007
- 2007-06-29 AU AU2007271232A patent/AU2007271232A1/en not_active Abandoned
- 2007-06-29 CN CNA2007800252509A patent/CN101506376A/zh active Pending
- 2007-06-29 EP EP07786944A patent/EP2044216A2/de not_active Withdrawn
- 2007-06-29 WO PCT/EP2007/056584 patent/WO2008003656A2/en active Application Filing
- 2007-06-29 CA CA002656140A patent/CA2656140A1/en not_active Abandoned
- 2007-06-29 KR KR1020097002135A patent/KR20090111307A/ko not_active Application Discontinuation
- 2007-06-29 JP JP2009517228A patent/JP2009540852A/ja active Pending
- 2007-06-29 US US12/309,478 patent/US20120141376A1/en not_active Abandoned
-
2008
- 2008-12-25 IL IL196184A patent/IL196184A0/en unknown
-
2009
- 2009-02-02 ZA ZA200900794A patent/ZA200900794B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009540852A5 (de) | ||
| Gallotta et al. | Inhaled TLR9 agonist renders lung tumors permissive to PD-1 blockade by promoting optimal CD4+ and CD8+ T-cell interplay | |
| JP2007537197A5 (de) | ||
| JP2018048138A (ja) | 診断及び治療のための腫瘍関連マーカーの同定 | |
| JP2006515749A5 (de) | ||
| JP2018509135A5 (de) | ||
| CA3110923A1 (en) | Process for preparing vaccine compositions | |
| JP2019502360A5 (de) | ||
| JP2010259438A5 (de) | ||
| DK1759013T3 (da) | Identificering af overflade-associerede antigener til tumordiagnose | |
| CN110799245A (zh) | 用于治疗具有非典型braf突变的癌症的组合物和方法 | |
| JP2006523453A5 (de) | ||
| JP2010516290A5 (de) | ||
| JP2009039107A5 (de) | ||
| WO2018148378A1 (en) | Modulating biomarkers to increase tumor immunity and improve the efficiacy of cancer immunotherapy | |
| US20060052322A1 (en) | Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent | |
| JP2012520663A5 (de) | ||
| EP2227558A1 (de) | Verfahren zur klassifizierung von krebspatienten als auf eine immuntherapie ansprechend bzw. nicht ansprechend | |
| RU2016138428A (ru) | Пептиды neil3 и включающие их вакцины | |
| JP2004505649A5 (de) | ||
| JP7289029B2 (ja) | 分子誘導システムペプチド及びその使用 | |
| KR20130055553A (ko) | 환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 | |
| RU2011127868A (ru) | Связанный с раком толстого кишечника ген том34 | |
| KR101881947B1 (ko) | 기생충 질병에 대한 백신 또는 진단용으로 사용되는 ｌ3 및/또는 ｌ5 공급원의 용도 | |
| JPWO2019162110A5 (de) |